title: [Scintigraphically "hot" thyroid nodules mainly go hand in hand with a normal TSH].
abstract: OBJECTIVE
  In recent years, various professional societies published guidelines for diagnostic evaluation of thyroid nodules, in which the indication for scintigraphy is restricted to patients with subnormal TSH values. It is seen controversial whether such recommendations should be transferred to Germany, partly because of lower iodine intake in this country and the consequent higher percentage of autonomous thyroid nodules, which are not accompanied by a measurable dysfunction. Since reliable data to this topic are scarce, we analyzed multicentrically the spectrum of scintigraphically "hot" and "warm" nodules under the current epidemiological conditions.
  
  
  METHODS
  In 10 German nuclear medicine out-patient institutions we evaluated the diagnostic data from a total of 514 patients, in whom unequivocally hyperfunctional nodules (focal increased uptake in comparison to perinodular tissue with a sonographically nodular correlative ≥1 cm) could be detected by (99m)Tc-pertechnetate scintigraphy. To minimize selection bias, the surveys were not carried out in hospitals.The recorded parameters included the thyroid hormone levels, the global (99m)Tc-uptake (TcTU), the size of each nodule and the total autonomous nodular volume (V(aut)).
  
  
  RESULTS
  Only 20% of the patients with "hot" nodules had subnormal TSH levels (<0.1 to 0.33 mU / l), the remaining patients had TSH levels from 0.34 to 3.5 mU /l (in one third of the patients TSH levels even exceeded 1.0 mU/l). Moreover, we found no relevant correlation between TSH and TcTU or V(aut).
  
  
  CONCLUSIONS
  In Germany, in at far the largest proportion of patients with autonomous thyroid nodules objectified by means of scintigraphy, TSH levels are within the normal range. Since such nodules with maximum safety can be classified as benign, a corresponding scintigraphic finding has a high priority for the patient. These current data support that it is not reasonable to restrict scintigraphy to patients with subnormal TSH values in this country.
authors.affiliation: Klinik für Nuklearmedizin, Universitätsklinikum Essen, Hufelandstr. 55, 4512 Essen, Germany. rainer.goerges@uni-due.de
authors.forename: Rainer
authors.initials: R
authors.lastname: Görges
authors.forename: T
authors.initials: T
authors.lastname: Kandror
authors.forename: S
authors.initials: S
authors.lastname: Kuschnerus
authors.forename: M
authors.initials: M
authors.lastname: Zimny
authors.forename: R
authors.initials: R
authors.lastname: Pink
authors.forename: H
authors.initials: H
authors.lastname: Palmedo
authors.forename: A
authors.initials: A
authors.lastname: Hach
authors.forename: H
authors.initials: H
authors.lastname: Rau
authors.forename: C
authors.initials: C
authors.lastname: Tanner
authors.forename: K
authors.initials: K
authors.lastname: Zaplatnikov
authors.forename: A
authors.initials: A
authors.lastname: Bockisch
authors.forename: L
authors.initials: L
authors.lastname: Freudenberg
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D005260:Female; D005858:Germany / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D011877:Radionuclide Imaging / Q000706:statistics & numerical data*; D015203:Reproducibility of Results; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors; D012680:Sensitivity and Specificity; D016606:Thyroid Nodule / Q000097:blood* / Q000000981:diagnostic imaging* / Q000453:epidemiology; D013972:Thyrotropin / Q000097:blood*; D055815:Young Adult
chemical_list: D014408:Biomarkers, Tumor; D013972:Thyrotropin